Syra Health Corp. Class A Common Stock (SYRA)
Filed: 27 Sep 23, 12:00am
SYRA HEALTH CORP.
1119 Keystone Way N. #201
Carmel, IN 46032
September 27, 2023
VIA EDGAR
United States Securities and Exchange Commission
100 F. Street, NE
Washington, DC 20549
| Attn: | Scott Stringer |
| Joel Parker | |
| Brian Fetterolf | |
| Erin Jaskot |
| Re: | Syra Health Corp. | |
| Registration Statement on Form S-1, as amended | ||
| File No. 333-271622 |
Ladies and Gentlemen:
Syra Health Corp. (the “Company”) hereby respectfully withdraws its request, dated September 22, 2023, that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 26, 2023. The Company intends to submit a revised acceleration request at a later date.
Please contact Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 if there are any questions with respect to this request.
| Thank you, | ||
| SYRA HEALTH CORP. | ||
| By: | /s/ Deepika Vuppalanchi | |
| Name: | Deepika Vuppalanchi | |
| Title: | Chief Executive Officer | |